Trial reportLasers in surgery and medicine2026
Effects of Vascular Photobiomodulation on Glycemic Control in Patients With Type II Diabetes Mellitus: A Prospective Single-Arm Clinical Study.
Trial report in Lasers in surgery and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the effects of laser photobiomodulation (PBM) using the systemic vascular technique (VPBM) on glycemic control in individuals with type 2 diabetes mellitus (T2DM) undergoing conventional pharmacological treatment.
methodsThis prospective single-arm clinical study was conducted at Centro Universitário UNITOP, in Palmas, Tocantins, Brazil. Individuals diagnosed with T2DM who had been receiving continuous oral hypoglycemic therapy with metformin (500 mg to 850 mg) for at least 6 months were included. PBM was applied transcutaneously over the radial artery using a low-level laser device emitting red light, aiming to promote systemic vascular irradiation. Capillary blood glucose levels were monitored through self-monitoring, while fasting plasma glucose and glycated hemoglobin (HbA1c) levels were analyzed in a certified clinical laboratory throughout the follow-up period.
resultsIn type 2 diabetes patients, VPBM induced significant acute reductions in capillary blood glucose immediately after all sessions (from averages over 180-220 mg/dL down to 119-129 mg/dL; p ≤ 0.0019). It also significantly lowered baseline fasting blood glucose over the 6-week protocol from 161.40 ± 32.63 mg/dL to 130.40 + 37.62 mg/dL (p = 0.0339). However, it showed no statistically significant effects on HbA1c: 7.61% to 7.65% or systolic blood pressure.
conclusionSystemic application of low-level laser therapy through the vascular technique, combined with standard oral hypoglycemic therapy, may contribute to improved glycemic control in individuals with T2DM. PBM associated with VPBM appears to represent a promising complementary therapeutic strategy for metabolic management in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.